With the global life science industry’s eyes set on San Francisco, Korea’s emerging or rising biopharma companies gathered in the Bay area to join the annual J.P. Morgan Healthcare Conference.
Samsung Biologics has filed another police report against departing employees set to join Lotte Biologics, alleging trade secret infringement.
BARCELONA, Spain — Lotte Biologics, a biopharmaceutical contract manufacturer, aims to go public by around 2027 to 2028, according to its CEO.
Samsung Biologics is eyeing new opportunities in Barcelona as it showcases its fifth plant at the CPHI Worldwide 2023 event, the world's largest pharmaceutical trade show.
CPHI Worldwide, the largest pharmaceutical trade show, started in Barcelona with major Korean biopharma players in attendance. Over 2,500 companies from 170 countries are exhibiting.
Lotte Biologics signed an agreement with Roche Diagnostics to further improve its contract development and manufacturing organization capabilities, the Korean company said Wednesday.
Samsung Biologics is seeking a preliminary injunction against Lotte Biologics for stealing trade secrets.
The memorandum of understanding (MOU) was signed by Lotte Biologics, Lotte Corporation, Incheon Metropolitan City and Incheon Free Economic Zone (IFEZ) on Tuesday at the IFEZ headquarters in Songdo, Incheon.
Officials pose for a commemorative photo at the plaque unveiling ceremony at Lotte Biologics' plant in Syracuse, New York, on Monday.
Lotte Biologics signed a memorandum of understanding with Switzerland-based ExcellGene to cooperate on the contract development organization (CDO) business.
Korea JoongAng Daily Sitemap